Home › NDC Lookup › RxCUI directory › RxCUI 260330

Methylprednisolone 4 MG Oral Tablet [Medrol] — RxCUI 260330

RxNorm drug concept · Semantic branded drug
RxCUI 260330 Semantic branded drug · SBD ● Current RxNorm concept 4 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI260330
Official nameMethylprednisolone 4 MG Oral Tablet [Medrol]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asMedrol 4 MG Oral Tablet
FDA products mapped4
Package NDCs mapped5
Reported Medicaid activity (SDUD)151 prescriptions · 5 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Methylprednisolone Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Methylprednisolone acetate injection is a steroid that calms inflammation and overactive immune reactions. It is used for things like rheumatoid arthritis, gout flares, bursitis, s...
  • A healthcare professional injects it into a muscle, a joint or soft tissue, or a skin lesion, depending on your condition. It should never go into the spinal canal. Your prescriber...
  • Some people notice more appetite, weight gain, fluid retention, trouble sleeping, mood changes, acne or higher blood sugar. You can also get thinning or a dent in the skin at the i...
  • Call for fever or other signs of infection, black or bloody stools, vision changes, swelling or shortness of breath, or severe mood changes. Get urgent help for swelling of the fac...
📖 Read our full Methylprednisolone Injection guide →

🕸️ Concept Web — How Methylprednisolone 4 MG Oral Tablet [Medrol] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Methylprednisolone 4 MG Oral Tablet [Medrol] RxCUI 260330

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Methylprednisolone 6902
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Medrol 202702
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Methylprednisolone Oral Tablet 372868
    • Methylprednisolone Oral Product 1163488
    • Methylprednisolone Pill 1163489
    • Methylprednisolone Oral Tablet [Medrol] 368772
    • Medrol Oral Product 1183796
    • Medrol Pill 1183797
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

  5. Packs 2

    Fixed collections of drugs packaged and sold together, like dose packs.

Showing up to 8 concepts per family — 15 of 16 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

📦 FDA Products & Package NDCs

4 products · 5 package NDCs
5 package NDCs map to RxCUI 260330 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00009-0020-01 100 TABLET in 1 BOTTLE (0009-0020-01) Medrol Pharmacia & Upjohn Company LLC 2013-09-20
00009-0022-01 25 TABLET in 1 BOTTLE (0009-0022-01) Medrol Pharmacia & Upjohn Company LLC 1957-10-24
00009-0056-02 100 TABLET in 1 BOTTLE (0009-0056-02) Medrol Pharmacia & Upjohn Company LLC 1957-10-24
00009-0056-04 1 DOSE PACK in 1 CARTON (0009-0056-04) / 21 TABLET in 1 DOS... Medrol Pharmacia & Upjohn Company LLC 1957-10-24
00009-0073-01 50 TABLET in 1 BOTTLE (0009-0073-01) Medrol Pharmacia & Upjohn Company LLC 1957-10-24
Observed labelers: Pharmacia & Upjohn Company LLC (5) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J7509 Methylprednisolone oral 5 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.